@mattiasmandorfer.bsky.social
📤 121
📥 110
📝 21
😀🇦🇹 multisociety (gastroenterology & hepatology, diabetology & obesity) consensus on MASLD (& MetALD!) 🤝Well-aligned with
@easlnews.bsky.social
CPGs 😟Reimbursement currently restricted to semaglutide for T2DM 🤔Reimbursement in your country? 🖇️:
rdcu.be/eLAde
#LiverSky
@georg-semmler.bsky.social
12 days ago
0
3
4
📰Disease-modifying effect of efruxifermin in compensated cirrhosis due to MASH: To miss the forest for the tree(s) 👉Cirrhosis regression only partially captures the potential therapeutic benefit of disease-modifying drugs in phase 3 🖇️ for explanation:
authors.elsevier.com/sd/article/S...
about 2 months ago
1
3
1
📰Disease-modifying effect of efruxifermin in compensated cirrhosis due to MASH: To miss the forest for the tree(s) 👉Cirrhosis regression only partially captures the potential therapeutic benefit of disease-modifying drugs in phase 3 🖇️ for explanation:
authors.elsevier.com/sd/article/S...
about 2 months ago
0
2
0
@bavenocoop.bsky.social
visiting the Japanese Society of Portal Hypertension 👀 at our auditorium 🙏 incredible hospitality 👉 See our 🇯🇵 friends at Baveno VIII
2 months ago
0
5
2
reposted by
GarciaPagan
4 months ago
I am very sad. My mentor and friend, Jaume Bosch, just has passed away. Thanks for everything, I will miss you. I would always remember our last day together celebrating a journey we begin together
@hospitalclinic.bsky.social
@idibaps.bsky.social
2
15
5
reposted by
The Baveno Cooperation: an EASL Consortium
4 months ago
🖤 With deep sorrow, we announce the passing of Prof. Dr. Jaime Bosch, President of the Baveno Cooperation. A brilliant scientist, inspiring leader, and dear friend. His immense legacy in hepatology will endure. Rest in peace, Jaime
0
9
5
Monitoring resmetirom by LSM - asking for the moon? Oftentimes mentioned but even more often forgotten: ❗️Random variation of LSM by VCTE exceeds 25% 👉🔽 LSM >25% often by chance, same for 'unchanged' or increases 👉No substitute for clinical judgement
#LiverSky
@georg-semmler.bsky.social
🔗👇
6 months ago
1
7
1
reposted by
Atoosa Rabiee
6 months ago
How often do u get asked to “clear” patients w/cirrhosis for surgery? How about “just” being on board?
#liversky
Well, if u want to get on board, here is your next read 👇🏼 Guidelines on abdominal surgery in patients w/cirrhosis
@jhepatology.bsky.social
www.journal-of-hepatology.eu/article/S016...
0
7
2
📢 First
@easlnews.bsky.social
CPG on surgery in cirrhosis presented today together with the one on TIPS! 🤝 See you at 10:30 Erlinger Room!
@bavenocoop.bsky.social
#LiverSky
add a skeleton here at some point
6 months ago
0
5
4
👏 Standing ovations for
@bavenocoop.bsky.social
's
@docberza.bsky.social
at the
@easlnews.bsky.social
Community Award presentation. Chapeau! What a wonderful person!
#LiverSky
7 months ago
1
12
4
Thirteen years ago when I was still an M.D. student, I was invited for my first oral presentation at an
@easlnews.bsky.social
event. 🙏 to EASL for inspiration, education & support throughout this journey as well as to my mentors & friends!
@bavenocoop.bsky.social
#LiverSky
7 months ago
1
16
5
‼️Following first hepatic decompensation, patients with severe
#AATD
have a higher risk of complications vs. other aetiologies 👉Early listing for liver transplantation.
#LiverSky
🔗https://doi.org/10.1016/j.jhepr.2024.101308
@easlnews.bsky.social
@jhepatology.bsky.social
8 months ago
0
6
1
Have you ever screened 25 patients for a single trial and randomized nearly as many? Vienna Hepatic Hemodynamic Lab advancing drug development for portal hypertension. Eager to see results ...
#LiverSky
@bavenocoop.bsky.social
8 months ago
0
9
2
Conversation with the Customs employee at the airport when entering the U.S. for a 1-day meeting: When is your flight back? - Tomorrow. - So they pay you well. - No, I'm in academia. - Oh, so they own you. 😋
8 months ago
1
2
0
@bavenocoop.bsky.social
Research Committee Baveno VIII Pre-Symposium, here we go! 👍 103 members watching online 👉 High interest in designing clinical studies on PH.
#liversky
9 months ago
0
7
2
I had the privilege to visit two top liver destinations in 🇪🇺 in the last couple of days - 🙏 enormous hospitality 🇨🇭Bern
@docberza.bsky.social
et al 🇮🇹Padova Alberto Zanetto et al 👀Summary slides attached!
#liversky
9 months ago
1
9
1
Challenge for
#liversky
: Monitoring regression/progression on resmetirom & deciding on alternative treatments ▶️ AASLD provided guidance ▶️ We commented on the role of LSM:
doi.org/10.1097/HEP....
‼️ Random variation in LSM >25% ‼️ Consider overall medical benefit (e.g., GLP-1)
9 months ago
0
8
4
👋 Bluesky 📰 Review: Non-invasive assessment of portal hypertension: Liver stiffness and beyond
@docberza.bsky.social
&
@juanabraldes.bsky.social
summarising the evidence for the upcoming
@bavenocoop.bsky.social
VIII in
@jhepatology.bsky.social
Reports 🔗https://doi.org/10.1016/j.jhepr.2024.101300
9 months ago
1
12
3
you reached the end!!
feeds!
log in